[1] 于成功, 吴寒. 质子泵抑制剂的临床应用与研究进展[J]. 中华消化内镜杂志, 2007, 24(1):74-75. [2] Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors[J]. BMJ (Clinical Research Ed.), 2008, 336(7634):2-3. [3] Saman Chubineh, John Birk. Proton Pump Inhibitors: The Good, the Bad, and the Unwanted[J]. Southern Medical Journal, 2012, 11(105):613-618. [4] 胡伏莲, 韩英, 孙忠实, 等. 消化系统合理用药专家圆桌会议纪要[J]. 中国医院用药评价与分析, 2006, 6(3):129-133. [5] Lanza F, Chan F, Quigley E. Guidelines for prevention of NSAID-related ulcer complications[J]. The American Journal f Gastroenterology.2009, 104(3):728-738. [6] 高申. 质子泵抑制剂临床应用的药学监护[M]. 人民卫生出版社, 2013:26-28. [7] 林三仁. 深入开展对胃食管反流病的标准化临床研究[J]. 中华内科杂志, 2011,50(8):625. [8] 中华医学杂志编辑委员会. 应激性溃疡防治建议[J]. 中华医学杂志, 2002, 82(14):1000-1001. [9] 中华人民共和国国家卫生和计划生育委员会. 国家卫生计生委等3部门关于加强合理用药健康教育工作的通知[EB/OL]. (2013-10-31)[2016-05-26]. http://www.nhfpc.gov.cn/xcs/s3581/201310/321ac9f2b1c24302a8b4ebde1280c54e.shtml. [10] 陈玫芬, 陈辉邦. 注射用泮托拉唑钠在4 种输液中的配伍稳定性[J]. 海峡药学, 2005, 17(5):20-22. [11] Juurlink D, Gomes T, Mamdani M, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J]. CMAJ: Canadian Medical Association Journal = Journal De L’association Medicale Canadienne. 2009, 180(7):713-718. [12] Clark D, Strandell J. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?[J]. European Journal Of Clinical Pharmacology, 2006, 62(6):473-479. [13] Suzuki K, Doki K, Kohda Y, et al. Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dosemethotrexate therapy[J]. British Journal Of Clinical Pharmacology. 2009, 67(1):44-49. |